{"id":"https://openalex.org/keywords/gp41","display_name":"gp41","description":"A transmembrane subunit of the HIV envelope glycoprotein complex involved in viral entry and targeted by neutralizing antibodies.","display_name_alternatives":["glycoprotein 41","gp-41","HIV envelope glycoprotein gp41"],"ids":{"openalex":"https://openalex.org/keywords/gp41","wikidata":null},"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.7495,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.7495,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0711,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"works_count":3083,"cited_by_count":110652,"works_api_url":"https://api.openalex.org/works?filter=keywords.id:keywords/gp41","updated_date":"2026-10-23T04:06:34","created_date":"2022-04-12T19:38:12"}